A Pennsylvania-based pharmaceutical firm and the FDA issued a recall of an injectable blood pressure medicine after a customer noticed "a visible black particulate matter" in a vial. Dr. Bernard Ashby ...
An injectable blood pressure drug called phenylephrine hydrochloride has been recalled after a customer noticed "a visible black particulate matter" in a vial of the product, raising the risk of ...
Little dark things shouldn’t be in vials of a drug, which is why one lot of an injection drug used to deal with low blood pressure under anesthesia got recalled. Provepharm said it pulled lot No.
Long-term exposure to fine particulate matter (PM₂.₅) and coarse particles (PM₁₀) significantly accelerates progression to end-stage renal disease (ESRD) among patients with biopsy-proven IgA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback